Accueil
Explorer
nav.journalClub
Tendances
Plus
synapse
⌘+K
Langue
Français
Français
March 3, 2026
GLP-1 Receptor Agonist Therapy Is Associated with Improved Outcomes of Arteriovenous Fistulae
JH
Joshua Hsu
BH
Bryan Ho
RS
Rahman Sayed
See all
Key Points
Improved outcomes of arteriovenous fistulae are associated with GLP-1 receptor agonist therapy, indicating potential benefits.
A significant correlation was noted, with a 30% enhancement in vascular health metrics among those receiving therapy.
Assessment involved a retrospective cohort analysis focusing on patients undergoing fistula procedures over a two-year period.
Findings support the potential of GLP-1 receptor agonists for enhancing vascular health in clinical settings.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Hsu et al. (Sun,) studied this question.
synapsesocial.com/papers/69a7683cbadf0bb9e87e4153
https://doi.org/https://doi.org/10.1016/j.jvs.2026.02.003
GLP-1 Receptor Agonist Therapy Is Associated with Improved Outcomes of Arteriovenous Fistulae | Synapse